Merck makes a difference in the lives of people globally through our innovative medicines, vaccines, biologic therapies, consumer care and animal health products. We aspire to be the best healthcare company in the world and are dedicated to providing leading innovations and solutions for tomorrow.

Research Grants 799 show all


$41.3M
2016

$86.7M
2017

$27.6M
2018

$45.4M
2019

$1.3M
2020

Publications 14,367 show all

  • 205
    Enzyme Inhibitors/pharmacology
  • 167
    Chromatography, High Pressure Liquid/methods
  • 164
    Drug Design
  • 140
    Diabetes Mellitus, Type 2/drug therapy
  • 128
    Anti-Bacterial Agents/pharmacology
  • 110
    Mass Spectrometry/methods
  • 99
    Drug Discovery
  • 99
    Pyridines/pharmacology
  • 93
    Piperidines/pharmacology
  • 89
    Pharmaceutical Preparations/metabolism

Patents 110,720show all

  • 29,756
    C07D - Heterocyclic compounds
  • 16,846
    A61K - Preparations for medical, dental, or toilet purposes
  • 9,115
    C07C - Acyclic or carbocyclic compounds
  • 6,548
    C09K - Materials for miscellaneous applications, not provided for elsewhere
  • 5,852
    C07K - Peptides
  • 3,885
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 3,576
    H01L - Semiconductor devices
  • 2,871
    C12N - Microorganisms or enzymes
  • 2,390
    Y02E - Reduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution
  • 2,259
    G01N - Investigating or analysing materials by determining their chemical or physical properties

Clinical Trials 5,504show all

1,472Phase 31,073Phase 2850N/A735Phase 1563Phase 4258Other

SEC Filings show all


217
8-K

78
10-Q

26
10-K

Contact Information

Kenilworth, NJ
United States